Edition Draft - Medsafe
Guideline on the Regulation of Therapeutic Products in New Zealand Part 4 : Manufacture of medicines Edition Draft October 2014
Download Edition Draft - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzRedipred – Data Sheet Page 3 of 11 dosage appear to be important factors in determining suppression of the pituitary adrenal axis and response to stress on cessation of steroid treatment.
Related documents
Guidelines for Product Recall and Product …
apps.who.intEdited-Final-Recall Guidelines 13 04 2010.doc v1.doc ii Guidelines for Product Recall and Product Withdrawal This document has been prepared to serve as a guide to
GUIDELINES FOR SUBMISION OF POST- APPROVAL …
apps.who.intguidelines for submision of post-approval variation medicine applications food, medicine and health care adminstration and control authority of ethiopia (efmhaca)
ANNEXURE E DEPARTMENT OF HEALTH It is the …
www.dpsa.gov.za9 implementation. Present guidelines and policies at the Committee and Medicines Control Council meetings. ENQUIRIES: Ms P Nkambule at Tel no (012) 395 8126/9470 POST 03/07: ASSISTANT DIRECTOR: MATERNAL AND NEONATAL HEALTH (REF NO:
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
MEDICINES AND RELATED SUBSTANCES ACT 101 …
www.hpcsa.co.zamedicines; to provide for the establishment of a pricing committee; to regulate the purchase and sale of medicines by manufacturers, distributors, wholesalers, pharmacists and persons licensed to dispense medicines; to make
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comRegistration of Medicines Table of Contents: Guidelines and Forms . 1.01_Contents_May18_v6.docx May 2018 . Page 2 of 7. 2.31 Fixed Dose Combination Products for HIV/Aids, Tuberculosis, and Malaria
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comAdministration Notification of Registration of Medicines 12.52 Notification of Registration Apr10v1.doc May 2010 Page 1 of 4 MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE
Related search queries
Guidelines for Product Recall and Product, Guidelines for Product Recall and Product Withdrawal, Post-approval variation medicine applications, MEDICINES, Guideline, E6R2, MEDICINES AND RELATED SUBSTANCES ACT, Of medicines, REGISTRATION OF MEDICINES, MEDICINES CONTROL COUNCIL, Notification, Registration, MEDICINES CONTROL COUNCIL NOTIFICATION